Synthesis and biological activity of olomoucine II. (Q44188865)

30 November 2017

Synthesis and biological activity of olomoucine II. (English)

1 reference

30 November 2017

1

1 reference

30 November 2017

2

1 reference

30 November 2017

5

Miroslav Strnad

1 reference

30 November 2017

Libor Havlícek

3

1 reference

30 November 2017

Marek Kuzma

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Bioorganic & Medicinal Chemistry Letters

30 November 2017

1 reference

30 November 2017

12

1 reference

30 November 2017

22

1 reference

30 November 2017

3283-3286

1 reference

CDK inhibition and cancer therapy

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900693-5

7 January 2021

Inhibition of cyclin-dependent kinases by purine analogues.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900693-5

7 January 2021

Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900693-5

7 January 2021

Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900693-5

7 January 2021

Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900693-5

7 January 2021

Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900693-5

7 January 2021

2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900693-5

7 January 2021

Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900693-5

7 January 2021

Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900693-5

7 January 2021

Cyclin-Dependent Kinase Inhibition by New C-2 Alkynylated Purine Derivatives and Molecular Structure of a CDK2−Inhibitor Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900693-5

7 January 2021

Docking-Based Development of Purine-like Inhibitors of Cyclin-Dependent Kinase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900693-5

7 January 2021

Preparation, physicochemical properties and biological activity of copper(II) complexes with 6-(2-chlorobenzylamino)purine (HL1) or 6-(3-chlorobenzylamino)purine (HL2). The single-crystal X-ray structure of.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900693-5

7 January 2021

Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900693-5

7 January 2021

10.1016/S0960-894X(02)00693-5

Identifiers

DOI

1 reference

release_a645vmujkrd6zlppyin4ir7z2i

30 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/a645vmujkrd6zlppyin4ir7z2i

24 November 2022

mapped directly with Wikidata item

1 reference